Does hypertension confer a hypercoagulable state?
- 1 July 1998
- journal article
- editorial
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 16 (7) , 913-916
- https://doi.org/10.1097/00004872-199816070-00003
Abstract
Although the blood vessels are exposed to high pressures in hypertension, the main complications of hypertension (stroke and myocardial infarction) are paradoxically thrombotic rather than haemorrhagic. In keeping with Virchow's triad, patients with hypertension do demonstrate abnormalities of vessel wall (endothelial dysfunction or damage), blood constituents (abnormal levels of haemostatic factors, platelet activation and fibrinolysis) and blood flow (rheology and flow reserve), suggesting that hypertension does confer a prothrombotic or hypercoagulable state. These abnormalities appear to be related to target organ damage and long-term prognosis and are altered by treatment. The observation that satisfactory blood pressure reduction with non-drug intervention and with various classes of antihypertensive drugs does not lead to an equal reduction in heart attacks and strokes may be due in part to unfavourable effects on the hypercoagulable state in hypertension. Antihypertensive agents with particular benefits in reducing this hypercoagulable state would be likely to have additional advantages in reducing the occurrence of stroke and other thromboembolic events. J Hypertens 16:913–916 © 1998 Lippincott-Raven Publishers.Keywords
This publication has 28 references indexed in Scilit:
- Hemostasis in normotensive and hypertensive menJournal Of Hypertension, 1998
- Evidence of platelet activation in hypertensionJournal of Human Hypertension, 1997
- von Willebrand factor and soluble E-selectin in hypertensionCoronary Artery Disease, 1996
- Relation of Hematocrit Values to Coronary Heart Disease, Arterial Hypertension, and Respiratory Impairment in Occupational and Population Groups of the Athens AreaAngiology, 1995
- Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart diseaseThe Lancet, 1993
- Rheological determinants of blood pressure in a Scottish adult populationJournal Of Hypertension, 1992
- Clinical perspective on celiprolol: Cardioprotective potentialAmerican Heart Journal, 1991
- The endothelium. Target and promoter of hypertension?Hypertension, 1990
- Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasPublished by Elsevier ,1990
- Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention TrialThe American Journal of Cardiology, 1985